$ALXN Income Statement

0
577

Alexion Pharmaceuticals, Inc. (ALXN)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 599,476   555,146   512,495   566,616  
Cost of Revenue 49,439 51,858 39,626 32,939
Gross Profit 550,037   503,288   472,869   533,677  
Operating Expenses
Research Development 129,110 100,661 92,554 191,457
Selling General and Administrative 183,776 157,665 159,477 129,291
Non Recurring 33,456 8,303 1,989 3,426
Others
Total Operating Expenses
Operating Income or Loss 203,695   236,659   218,849   209,503  
Income from Continuing Operations
Total Other Income/Expenses Net 2,195 205 512 3,471
Earnings Before Interest And Taxes 205,890 236,864 219,361 212,974
Interest Expense 549 655 715 1,063
Income Before Tax 205,341 236,209 218,646 211,911
Income Tax Expense 52,009 58,478 52,151 52,557
Minority Interest
Net Income From Continuing Ops 153,332 177,731 166,495 159,354
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income 153,332   177,731   166,495   159,354  
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares 153,332   177,731   166,495   159,354  

LEAVE A REPLY

Please enter your comment!
Please enter your name here